Analyst firms · Evercore ISI · FTRE
Evercore ISI FTRE price target and rating history
Fortrea Holdings Inc. (FTRE) · Health Care
Evercore ISI rates Fortrea Holdings Inc. (FTRE) Outperform with a $25 price target, as of its latest action on Jan 6, 2026. It has published 4 rating actions on FTRE since September 2023, including 2 upgrades and 1 downgrade. Across 7 firms with a FTRE price target in the last 12 months, the median target is $22. Evercore ISI's $25 is 14% above that.
- Current rating
- Outperform
- Price target
- $25
- Median target, all firms
- $22
- Actions on FTRE
- 4
Evercore ISI price target on FTRE
Every Evercore ISI rating on FTRE
- Jan 6, 2026
- Aug 8, 2024
- Dec 1, 2023
- Sep 14, 2023
How other firms rate FTRE
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Deutsche Bank | Buy | $25 | Oct 15, 2026 |
| Barclays | Overweight | $23 | Oct 6, 2026 |
| UBS | Neutral | $22 | Sep 30, 2026 |
| TD Cowen | Buy | $15 | Mar 9, 2026 |
| Truist Securities | Buy | $22 | Jan 8, 2026 |
| Evercore ISI | Outperform | $25 | Jan 6, 2026 |
| Citigroup | Buy | $21 | Dec 11, 2025 |
Questions about Evercore ISI and FTRE
- What is Evercore ISI's price target for FTRE?
- Evercore ISI's latest stated price target for Fortrea Holdings Inc. (FTRE) is $25, from its action on Jan 6, 2026.
- What is Evercore ISI's rating on FTRE?
- Evercore ISI rates FTRE Outperform, a bullish rating, as of Jan 6, 2026.
- When did Evercore ISI last change its view on FTRE?
- On Jan 6, 2026, Evercore ISI upgrades to Outperform from In-line, price target $25.
- How does Evercore ISI's FTRE target compare with other analysts?
- Across 7 firms with a FTRE price target in the last 12 months, the median target is $22. Evercore ISI's $25 is 14% above that.
More FTRE rating histories
All Evercore ISI ratingsFTRE news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.